Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HUGS therapy aims to strengthen Mother-Baby bond after postpartum depression

NCT ID NCT05209789

Symptom relief Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a group therapy program called HUGS for mothers with postpartum depression. The goal was to see if it improves the mother-baby relationship compared to a playtime group. 104 mothers participated, and researchers measured bonding through video analysis. The therapy focuses on positive interactions and support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
group therapy (HUGS program)
What this could lead to
If it works, this could provide a simple, non-drug way to help mothers with postpartum depression bond better with their babies.
What could go wrong
This is a small, completed trial with 104 participants, so results may not apply to all mothers. The therapy is behavioral, so benefits depend on engagement and may not be dramatic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

104 people

The number who actually took part.

Started

Dec 2023

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria regarding the mother: * Person affiliated or beneficiary of a social security plan; * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research); * Woman who gave birth in one of the maternity hospitals participating in the study; * Diagnosis of postpartum depression made by the perinatal psychiatry team according to the clinical criteria of the DSM-5; * Time to onset of depressive symptoms within the first 12 months after childbirth; * Treatment for postpartum depression that started at least 8 weeks ago with improved mood as assessed by the psychiatrist. Inclusion criteria for the baby: * Baby aged less than 1 year at inclusion; * Twins will be able to participate in the study and benefit from the interventions; Non-inclusion criteria concerning the mother: * Uncontrolled substance use disorder; * Presence of suicidal ideas at inclusion; * Manic episode of a bipolar disease * Psychiatric pathology decompensated upon inclusion and corresponding to the following list: Schizophrenic disorder, Schizoaffective disorder, Mood disorders with psychotic symptoms; * Non French speaker. Non-inclusion criteria for the baby: \- Baby hospitalized or having sustained medical care upon inclusion in the context of a somatic pathology.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post partum depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post partum depression

Contacts and locations

Locations

  • Bordeaux Public Hospital

    Bordeaux, France

  • Havre Public Hospital Maternity

    Le Havre, France

  • Reims Public Hospital Maternity

    Reims, France

  • Rouen Public Hospital Maternity

    Rouen, France

  • Toulouse Child Guidance

    Toulouse, France

  • Toulouse Joseph Ducuing Maternity

    Toulouse, France

  • Toulouse Public Hospital Maternity

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.